Resistance to antibiotics is a serious threat to global public health

May 8, 2014

The World Health Organisation, WHO, recently published its first Global Report on Antimicrobial Resistance. This publication demonstrates that resistance against antibiotics is a serious threat to global public health. The findings of such report reinforce the views on the need for further prevention of Carl Eric Nord, who is a senior professor at the Institution for Laboratory Medicine at the Karolinska Institute in Stockholm, Sweden.

Nord was involved, as a partner, in the EU-funded project ANTIRESDEV, which was completed in 2013. The project focused on studying the emergence and persistence of and their effect on the composition of the microbe populations living in our intestine, referred to as microflora. This project resulted in the development of three DNA biochips for rapidly screening of resistant genes in disease-causing bacteria. Nord talks to youris.com about how European medical research can contribute to the surveillance of threats.

The antibiotic-resistant bacterium Clostridium difficile, covered in the ANTIRESDEV project, is not among the seven bacteria covered in the latest WHO report. Why not?

WHO is an international body and looks at the very poor developing as well as at the developed countries. Clostridium difficile is a problem for the rich countries. It is a kind of side effect of antibiotic treatment in compromised patients. These patients are mostly elderly, rather sick and have often even other diseases. When you treat them with an antibiotic which changes the intestinal microflora, then colonisation with Clostridium difficile can result in a serious infection. In developing countries, they do not look for a changed microflora and are not prepared to do this, as we heard from colleagues in those countries. Thus, WHO in Geneva, which looks into all countries, has to make different recommendations.

The video will load shortly

What can be done in order to mitigate or even prevent antibiotic resistance?

Hygiene is the most important action to prevent infections. Special hand hygiene procedures are the most important. Also antimicrobial agents used for cleaning and treatment of infections have to be used in the correct way. Otherwise, you select just the resistant bacteria especially in the intensive care units.

How can we adopt the coordinated action called for by the WHO to minimise emergence and spread of antimicrobial resistance?

This coordinated action is the right way to go about prevention. But, unfortunately, we have a problem in many countries, we do not any longer have an effective infection control, as we used to have it earlier with special nurses for infection control.

In Scandinavian countries, which are small, we have rather few patients with complicated infections. However, we have many tourists travelling from Sweden to other countries, especially Asia. They will be colonised with when they are there. Although they will not develop infections themselves, they can spread it when they come back. In order to become sick you have to be compromised. If you have a balanced intestinal microflora, it is not likely that you will be infected.

In order to increase prevention, how soon could the project's rapid screening biochips be introduced in clinics?

It depends on the cost. One of the problems in laboratory medicine nowadays is economy. That is the problem in most European and other well developed countries. You have a fixed budget for doing laboratory analyses. And if it costs too much, then you cannot do it. You can do it from the scientific point of view. That is not a problem. But in general the prices for molecular biological tests are still high, they are very expensive.

Explore further: CDC addresses burden, threat of antibiotic resistance

Related Stories

CDC addresses burden, threat of antibiotic resistance

January 6, 2014
(HealthDay)—The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

Antibiotic resistance giving killer diseases free rein, WHO says (Update 2)

April 30, 2014
The rise of superbugs, stoked by misuse of antibiotics and poor hospital hygiene, is enabling long-treatable diseases to once again become killers, the World Health Organization warned on Wednesday.

Number of patients admitted with antibiotic-resistant infections rising

March 25, 2014
The emergence of community-acquired infections, such as urinary tract infections (UTI), due to strains resistant to common antibiotics are on the rise, according to Rhode Island Hospital researchers. The study is published ...

Joining forces globally against drug resistant bacteria

April 2, 2014
Antibiotics have saved millions of lives from once deadly infectious diseases. But, misuse of antibiotics and other antimicrobials in humans and animals has led to bacteria evolving resistance.

Is there a way to slow the process of bacterial antibiotic resistance?

April 10, 2014
Continually under attack by noxious substances in their environments, bacteria have developed many clever mechanisms to survive. When confronted with an antibiotic, they can destroy it with enzymes, rendering it harmless. ...

CDC sounds alarm on antibiotic-resistant bacteria

September 16, 2013
(HealthDay)—More than 2 million people come down with infections from antibiotic-resistant bacteria every year in the United States, leading to at least 23,000 deaths, according to a report released Monday by federal health ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.